Resmed to Expand Sleep Portfolio With $340M Acquisition of Restless Legs Syndrome Device Maker
Resmed will acquire the manufacturer of an FDA-cleared nerve stimulation device for refractory RLS, a move that leverages its existing sleep physician and home medical equipment channels.